Filter
Period
Filter by
recent search
Showing: 1 – 05 of 127 Regulated Information
–
27 June 2022
27 June 2022
LinkedIn
Facebook
Ipsen to acquire Epizyme, expanding its portfolio in oncology
PARIS, FRANCE & CAMBRIDGE, MASSACHUSETTS, 27 June 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today announced that they have entered into a definitive merger agreement under which Ipsen will acquire Epizyme. The transaction was unanimously approved by…
–
21 June 2022
21 June 2022
LinkedIn
Share buyback program – Ipsen reporting from 13 june to 17 June 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
14 June 2022
14 June 2022
LinkedIn
Share buyback program – Ipsen reporting from 06 june to 10 June 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
01 June 2022
01 June 2022
LinkedIn
Ipsen initiates a share buy-back program to cover its employee free share-allocation plan
This article or press release has no online content. Please download the associated documents for more information.
–
03 May 2022
03 May 2022
LinkedIn